Tissue converters, like any other product manufacturer, must keep current on equipment in order to remain competitive and efficiently meet customer demand. Doing so generally requires a substantial investment that is carefully considered from all business angles before being made. The global COVID-19 pandemic introduces another layer of deliberation: Will increased tissue consumption continue or reach its peak? Will supply chain disruptions become less or more severe? How might employment volatility affect the future?
Questions abound, but that shouldn’t dissuade tissue converters from investing in equipment. In fact, it may be an opportune time to make a purchase.